Latest News for: Pharmaceutical sources

Edit

Global Vietnam Generic Drugs Market Report 2022: Quickly Developing National Pharmaceutical Industry Driving Growth - ResearchAndMarkets.com

Eagle-Tribune 30 Sep 2022
The "Vietnam Generic Drugs Market, By Type (Small Molecule Generics v/s Biosimilars), By Mode of Drug Delivery (Oral, Topical, Parenteral, Others), By Form, By Source, By Distribution Channel, By Application, By Region, Competition Forecast & Opportunities, 2027" report has been added to ResearchAndMarkets.com's offering ... HEALTH PHARMACEUTICAL.
Edit

KalVista Pharmaceuticals to Present at the 2022 HAEi Global Leadership Workshop

Cadillac News 30 Sep 2022
KalVista Pharmaceuticals, Inc ... About KalVista Pharmaceuticals, Inc. KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors for diseases with significant unmet need ... KalVista Pharmaceuticals, Inc ... SOURCE. KalVista Pharmaceuticals, Inc.
Edit

Consider geo-political factors before framing policy: PM Modi

The Times of India 30 Sep 2022
While asking top civil servants to factor in geo-political and strategic considerations while designing policies and schemes, PM Narendra Modi has pointed to India's high dependence on China to source pharmaceutical ingredients, an issue that was flagged by the office of the National Security Advisor.
Edit

Vietnam Tuberculosis Therapeutics Market Report to 2028 - Featuring Novartis Vietnam, Johnson & Johnson, Otsuka ...

Eagle-Tribune 30 Sep 2022
Growing demands for effective treatment and efficient pharmaceuticals to control the growing instances of tuberculosis is driving the market growth ... Companies MentionedNovartis Vietnam Co., Ltd.Johnson & JohnsonOtsuka Pharmaceutical Vietnam JSCLupin LimitedGSK Vietnam ... INFECTIOUS DISEASES PHARMACEUTICAL HEALTH. SOURCE.
Edit

Entos Pharmaceuticals franchit une étape importante en matière d'inscription de participants dans l'essai clinique de ...

The Joplin Globe 30 Sep 2022
Lewis, Ph.D., Fondateur et PDG d'Entos Pharmaceuticals ... À propos de la société Entos Pharmaceuticals ... La traduction devra toujours être confrontée au texte source, qui fera jurisprudence. Consultez la version source sur businesswire.com .https.//www.businesswire.com/news/home/20220929005142/fr/ ... Contact d'entreprise chez Entos Pharmaceuticals. ... SOURCE.
Edit

BiondVax announces financial plans to support its ongoing NanoAb pipeline development

Victoria Advocate 30 Sep 2022
30, 2022 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd ... BiondVax Pharmaceuticals Ltd ... With highly experienced pharmaceutical industry leadership, BiondVax is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized antibody (NanoAb) pipeline ... SOURCE Biondvax Pharmaceuticals Ltd.
Edit

Amylyx Pharmaceuticals Announces FDA Approval of RELYVRIO™ for the Treatment of ALS

Cadillac News 30 Sep 2022
Amylyx Pharmaceuticals, Inc. (NASDAQ ... About Amylyx Pharmaceuticals. Amylyx Pharmaceuticals, Inc ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20220929005962/en/ ... Amylyx Pharmaceuticals, Inc ... RESEARCH FDA NEUROLOGY CLINICAL TRIALS BIOTECHNOLOGY MANAGED CARE HEALTH PHARMACEUTICAL SCIENCE. SOURCE. Amylyx Pharmaceuticals, Inc.
Edit

Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial for RP-A501 in Danon Disease ...

The Facts 30 Sep 2022
Rocket Pharmaceuticals, Inc ... About Rocket Pharmaceuticals, Inc. Rocket Pharmaceuticals, Inc ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20220930005139/en/ ... BIOTECHNOLOGY PHARMACEUTICAL HEALTH CLINICAL TRIALS. SOURCE. Rocket Pharmaceuticals, Inc.
Edit

Thinking about buying stock in First Wave BioPharma, Amylyx Pharmaceuticals, IonQ, Arcimoto, or Ardelyx?

Victoria Advocate 30 Sep 2022
NEW YORK, Sept ... FWBI. https.//www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=FWBI&prnumber=093020221AMLX ... (Note ... �. View original content to download multimedia.https.//www.prnewswire.com/news-releases/thinking-about-buying-stock-in-first-wave-biopharma-amylyx-pharmaceuticals-ionq-arcimoto-or-ardelyx-301637760.html. SOURCE InvestorsObserver ... ....
Edit

Thinking about buying stock in F45 Training, Edesa Biotech, Amyris, Carnival Corp, or Intercept Pharmaceuticals?

Longview News-Journal 30 Sep 2022
NEW YORK, Sept ... FXLV. https.//www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=FXLV&prnumber=093020222EDSA ... View original content to download multimedia.https.//www.prnewswire.com/news-releases/thinking-about-buying-stock-in-f45-training-edesa-biotech-amyris-carnival-corp-or-intercept-pharmaceuticals-301637848.html. SOURCE InvestorsObserver ... ....
Edit

Global Immunotherapy Market Research and Forecast, 2022-2028: Featuring AstraZeneca, Gilead, Novartis, Merck & Others - ResearchAndMarkets.com

Eagle-Tribune 30 Sep 2022
DUBLIN--(BUSINESS WIRE)--Sep 30, 2022--. The "Global Immunotherapy Market Research and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering ... Segmental Outlook ... Regional Outlooks ... 1 ... 2 ... 3 ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20220930005298/en/ ... BIOTECHNOLOGY PHARMACEUTICAL HEALTH. SOURCE ... .
Edit

Monkeypox rapid PCR test in development

Eagle-Tribune 30 Sep 2022
EVANSTON, Ill.--(BUSINESS WIRE)--Sep 29, 2022-- ... Food and Drug Administration ... This press release features multimedia ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20220929005959/en/ ... BIOTECHNOLOGY FDA OTHER HEALTH HEALTH GENERAL HEALTH PHARMACEUTICAL OTHER SCIENCE RESEARCH INFECTIOUS DISEASES SCIENCE COVID-19. SOURCE ... .
Edit

Europe Over-the-counter (OTC) Drugs Market Report 2022: Increasing Self-medication Practices Driving 5.4% Annual Growth - ResearchAndMarkets.com

Eagle-Tribune 30 Sep 2022
DUBLIN--(BUSINESS WIRE)--Sep 30, 2022--. The "Europe Over-the-counter (OTC) Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)" report has been added to ResearchAndMarkets.com's offering ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20220930005390/en/. CONTACT ... HEALTH PHARMACEUTICAL. SOURCE ... PUB.
Edit

Zoetis Announces the Completion of its Acquisition of Jurox, a Leading Provider of Livestock and ...

The Galveston Daily News 30 Sep 2022
PARSIPPANY, N.J. & RUTHERFORD, New South Wales, Australia--(BUSINESS WIRE)--Sep 30, 2022--. Zoetis Inc. (NYSE ... AboutZoetis ... For more information, visit www.zoetis.com. About Jurox ... ZTS-IR. View source version on businesswire.com.https.//www.businesswire.com/news/home/20220929005878/en/ ... BIOTECHNOLOGY OTHER HEALTH HEALTH VETERINARY PHARMACEUTICAL. SOURCE.
Edit

CXL Ophthalmics Announces $32 Million Series A Investment Round Led by AXA IM Alts, Through ...

Eagle-Tribune 30 Sep 2022
SHERBORN, Mass.--(BUSINESS WIRE)--Sep 30, 2022-- ... “EpiSmart has the potential to be a game-changer for the treatment for keratoconus ... View source version on businesswire.com.https.//www.businesswire.com/news/home/20220930005330/en/ ... RESEARCH FINANCE FDA CLINICAL TRIALS PROFESSIONAL SERVICES BIOTECHNOLOGY PHARMACEUTICAL HEALTH OPTICAL SCIENCE. SOURCE ... .

Most Viewed

Russian President Vladimir Putin chairs a meeting with the heads of delegations to the 18th meeting of the Conference of Heads of Security and Intelligence Agencies of the Commonwealth of Independent States members via videoconference at the Kremlin in Moscow, Russia, Thursday, Sept. 29, 2022
AP / Gavriil Grigorov, Sputnik, Kremlin Pool Photo
×